Loneliness and depression have taken a toll on millions of people during the COVID-19 pandemic, but cancer patients have been particularly hard hit. (Cancer)
AstraZeneca announced that durvalumab (Imfinzi) plus tremelimumab and chemotherapy significantly improved overall survival in unresectable stage III non-small cell lung cancer as compared with chemotherapy alone.
CRISPR Therapeutics and Nkarta announced a collaboration to develop gene-edited cell therapies for cancer.
Illumina clapped back at the Federal Trade Commission’s opposition to the company’s plan to reacquire cancer testing company Grail. (Wall Street Journal)
Perioperative treatment with erythropoietin failed to improve erectile function after surgery for prostate cancer. (Journal of Urology)
A higher nurse-to-patient ratio in hospitals was associated with fewer deaths, earlier discharge, and lower readmission rates. (The Lancet)
Drinking two or more sugar-sweetened drinks daily significantly increased the risk of colorectal cancer in women younger than 50. (Gut)
When checking your body for signs of skin cancer, don’t overlook the nails. (American Academy of Dermatology)
The average cost of dying — including end-of-life care and funerals — is approaching $20,000, with Hawaii leading the way at $36,000. (Axios)
“Will cancer make me infertile?” (Cancer Research UK)
Source: MedicalNewsToday.com
